Catalyst Pharmaceuticals Inc (CPRX)
14.99
+0.27
(+1.83%)
USD |
NASDAQ |
May 06, 16:00
14.99
0.00 (0.00%)
After-Hours: 20:00
Catalyst Pharmaceuticals Price to Book Value: 4.555 for May 6, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 03, 2024 | 4.473 |
May 02, 2024 | 4.564 |
May 01, 2024 | 4.619 |
April 30, 2024 | 4.573 |
April 29, 2024 | 4.628 |
April 26, 2024 | 4.524 |
April 25, 2024 | 4.461 |
April 24, 2024 | 4.594 |
April 23, 2024 | 4.476 |
April 22, 2024 | 4.588 |
April 19, 2024 | 4.598 |
April 18, 2024 | 4.661 |
April 17, 2024 | 4.862 |
April 16, 2024 | 4.722 |
April 15, 2024 | 4.676 |
April 12, 2024 | 4.625 |
April 11, 2024 | 4.804 |
April 10, 2024 | 4.825 |
April 09, 2024 | 4.798 |
April 08, 2024 | 4.713 |
April 05, 2024 | 4.610 |
April 04, 2024 | 4.594 |
April 03, 2024 | 4.707 |
April 02, 2024 | 4.637 |
April 01, 2024 | 4.783 |
Date | Value |
---|---|
March 28, 2024 | 4.844 |
March 27, 2024 | 4.944 |
March 26, 2024 | 4.786 |
March 25, 2024 | 4.819 |
March 22, 2024 | 4.780 |
March 21, 2024 | 5.050 |
March 20, 2024 | 5.138 |
March 19, 2024 | 4.980 |
March 18, 2024 | 4.886 |
March 15, 2024 | 4.883 |
March 14, 2024 | 4.920 |
March 13, 2024 | 5.050 |
March 12, 2024 | 4.923 |
March 11, 2024 | 4.892 |
March 08, 2024 | 4.938 |
March 07, 2024 | 5.056 |
March 06, 2024 | 4.819 |
March 05, 2024 | 4.944 |
March 04, 2024 | 5.072 |
March 01, 2024 | 5.169 |
February 29, 2024 | 4.871 |
February 28, 2024 | 4.424 |
February 27, 2024 | 4.360 |
February 26, 2024 | 4.309 |
February 23, 2024 | 4.310 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.965
Minimum
Sep 30 2020
12.09
Maximum
Sep 11 2019
4.447
Average
4.111
Median
Oct 26 2023
Price to Book Value Benchmarks
Pfizer Inc | 1.792 |
Sarepta Therapeutics Inc | 13.28 |
PTC Therapeutics Inc | -- |
Corcept Therapeutics Inc | 4.551 |
Cytokinetics Inc | -- |
Price to Book Value Related Metrics
PE Ratio | 24.57 |
PS Ratio | 4.216 |
Price to Free Cash Flow | 27.14 |
Price | 14.99 |
Earnings Yield | 4.07% |
Market Cap | 1.767B |
Operating PE Ratio | 19.34 |
Normalized PE Ratio | 24.57 |